NCT00764686

Brief Summary

Ankylosing Spondylitis(AS) is a chronic, inflammatory, rheumatic disease (Khan, 2002). AS is associated with increased work disability and use of healthcare resources (Ward et al, 2008). Evidence suggests that group exercise is the most effective form of physiotherapy management for individuals with Ankylosing Spondylitis (Dagfinrud et al, 2008). To date, no research has been published in relation to short, intensive group exercise programmes. This study aims to investigate the effects of a five day exercise and education programme for individuals with Ankylosing Spondylitis. Effects of the programme on disease activity, function and spinal mobility will be measured using using validated quantitative measures; the overall value of the programme for patients will be explored by means of semi-structured interviews.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jun 2008

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 1, 2008

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 2, 2008

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2009

Completed
Last Updated

September 29, 2009

Status Verified

September 1, 2009

Enrollment Period

4 months

First QC Date

October 1, 2008

Last Update Submit

September 28, 2009

Conditions

Keywords

ExerciseEducationHydrotherapyPhysical Therapy Modalities

Outcome Measures

Primary Outcomes (1)

  • Bath Ankylosing Spondylitis Metrology Index (BASMI)

    Pre-intervention, post-intervention and 4-week follow-up

Secondary Outcomes (3)

  • Bath Ankylosing Spondylitis Functional Index (BASFI)

    Pre-intervention, post intervention and 4-week follow-up

  • Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

    Pre-intervention, post-intervention and 4-week follow-up.

  • Semi-structured interview

    Post-intervention

Study Arms (2)

1

EXPERIMENTAL

Low disease severity group

Other: Exercise and Education

2

EXPERIMENTAL

Higher disease severity group

Other: Exercise and Education

Interventions

One hydrotherapy class, one land-exercise class and one education session daily, for five days. Each exercise class and education session is one hour in duration.

2

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A diagnosis of Ankylosing Spondylitis according to the modified New York criteria

You may not qualify if:

  • Patients for whom hydrotherapy or land-exercise have been contra-indicated
  • Cognitive Impairment
  • Patients unwilling to give informed, written consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mater Misericordiae University Hospital

Dublin, Ireland

Location

MeSH Terms

Conditions

Spondylitis, AnkylosingMotor Activity

Interventions

ExerciseEducational Status

Condition Hierarchy (Ancestors)

Axial SpondyloarthritisSpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesAnkylosisJoint DiseasesArthritisBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaSocioeconomic FactorsPopulation Characteristics

Study Officials

  • Anne-Marie Keown, BSc MSc

    Mater Misericordiae University Hospital

    PRINCIPAL INVESTIGATOR
  • Tara Cusack, PhD

    University College Dublin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 1, 2008

First Posted

October 2, 2008

Study Start

June 1, 2008

Primary Completion

October 1, 2008

Study Completion

January 1, 2009

Last Updated

September 29, 2009

Record last verified: 2009-09

Locations